Exicure, Inc.
General ticker "XCUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $32.8M (TTM average)
Exicure, Inc. does not follow the US Stock Market performance with the rate: -33.8%.
Estimated limits based on current volatility of 7.1%: low 1.57$, high 1.80$
Factors to consider:
- Total employees count: 8 (+14.3%) as of 2025
- Top business risk factors: Limited resources, Need for additional capital, Strategic risks and growth management, Labor/talent shortage/retention, Cybersecurity threats
- Current price 20.2% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.11$, 6.25$]
- 2026-12-31 to 2027-12-31 estimated range: [1.46$, 4.46$]
Financial Metrics affecting the XCUR estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: 19.19 < Shareholder equity ratio, % of 27.96 <= 42.57
- Negative: Investing cash flow per share per price, % of -4.95 <= -4.39
Short-term XCUR quotes
Long-term XCUR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.50MM | $0.00MM |
| Operating Expenses | $15.00MM | $12.73MM | $4.23MM |
| Operating Income | $-15.00MM | $-12.23MM | $-4.23MM |
| Non-Operating Income | $-1.92MM | $2.54MM | $-1.35MM |
| Interest Expense | $0.00MM | $0.02MM | $0.00MM |
| R&D Expense | $1.42MM | $0.00MM | $3.29MM |
| Income(Loss) | $-16.91MM | $-9.69MM | $-5.58MM |
| Taxes | $0.00MM | $0.01MM | $-0.63MM |
| Net Income(Loss)* | $-16.91MM | $-9.70MM | $-4.95MM |
| Stockholders Equity | $3.03MM | $6.77MM | $3.93MM |
| Assets | $11.58MM | $15.06MM | $14.04MM |
| Operating Cash Flow | $-10.36MM | $-2.91MM | $-8.55MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-1.08MM | $0.00MM | $-1.81MM |
| Financing Cash Flow | $3.67MM | $13.40MM | $1.60MM |
| Earnings Per Share** | $-2.11 | $-1.59 | $-0.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.